APA (7th ed.) Citation

Miyoshi, J., Maeda, T., Matsuoka, K., Saito, D., Miyoshi, S., Matsuura, M., . . . Hisamatsu, T. (2021). Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis. Nature Portfolio.

Chicago Style (17th ed.) Citation

Miyoshi, Jun, Tsubasa Maeda, Katsuyoshi Matsuoka, Daisuke Saito, Sawako Miyoshi, Minoru Matsuura, Susumu Okamoto, Satoshi Tamura, and Tadakazu Hisamatsu. Machine Learning Using Clinical Data at Baseline Predicts the Efficacy of Vedolizumab at Week 22 in Patients with Ulcerative Colitis. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Miyoshi, Jun, et al. Machine Learning Using Clinical Data at Baseline Predicts the Efficacy of Vedolizumab at Week 22 in Patients with Ulcerative Colitis. Nature Portfolio, 2021.